Innovative Use of World’s First Malaria Vaccine Generates Remarkable Results and a Life-Saving Opportunity

RTS,S is the first malaria vaccine shown to reduce malaria and life-threatening severe malaria in young children. Approximately 2.1 million doses of the vaccine have been provided and more than 750,000 children have received their first vaccine dose through the pilot programme where malaria risks occur year-round

Malaria still kills 400,000 people every year, most of them African children under five years old. RTS,S is the first malaria vaccine shown to reduce malaria and life-threatening severe malaria in young children. Credit: Mercedes Sayagues/IPS

Sep 1 2021 (IPS) – In the midst of the tragedy and turmoil caused by the COVID-19 pandemic, it’s gratifying to…

Is Our Academic System Ready for a New Coronavirus Normal?

Institutions of higher education have a responsibility to lead by example and to provide current, high-quality information to the people and communities that support them. This responsibility is no clearer than during a public health and information crisis like the one presented by this novel coronavirus. State and local governments in particular should be able to rely on Universities for guidance on protective evidence-based precautionary measures, whether it’s cancelling events, closing schools or formulating public health postings.

Credit: Pîxabay.

ILLINOIS, United States, Mar 11 2020 (IPS) – Institutions of higher education have a responsibility to lead by example …